Clinical Trial

Hypersensitivity to Adrenomedullin in Post-Traumatic Headache

Recruiting
View on ClinicalTrials.gov →
Summary
Adrenomedullin is a neuropeptide implicated in the pathogenesis of headache. This study investigates whether adrenomedullin induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-01.
Trial Details
NCT Number NCT07059546
Lead Sponsor Danish Headache Center
Conditions Posttraumatic Headache
Enrollment 21 participants
Start Date 2025-08-01
Primary Completion 2028-05-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-30